AAAAAA
Results:
1-12
|
Results: 12
Authors:
Tooyama, I
Sato, H
Yasuhara, O
Kimura, H
Konishi, Y
Shen, Y
Walker, DG
Beach, TG
Sue, LI
Rogers, J
Citation: I. Tooyama et al., Correlation of the expression level of C1q mRNA and the number of C1q-positive plaques in the Alzheimer disease temporal cortex analysis of C1q mRNA and its protein using adjacent or nearby sections, DEMENT G C, 12(4), 2001, pp. 237-242
Authors:
Kuo, YM
Beach, TG
Sue, LI
Scott, S
Layne, KJ
Kokjohn, TA
Kalback, WM
Luehrs, DC
Vishnivetskaya, TA
Abramowski, D
Sturchler-Pierrat, C
Staufenbiel, M
Weller, RO
Roher, AE
Citation: Ym. Kuo et al., The evolution of A beta peptide burden in the APP23 transgenic mice: Implications for A beta deposition in Alzheimer disease, MOL MED, 7(9), 2001, pp. 609-618
Authors:
Beach, TG
Kuo, YM
Schwab, C
Walker, DG
Roher, AE
Citation: Tg. Beach et al., Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmine, NEUROSCI L, 310(1), 2001, pp. 21-24
Authors:
Kuo, YM
Kokjohn, TA
Beach, TG
Sue, LI
Brune, D
Lopez, JC
Kalback, WM
Abramowski, D
Sturchler-Pierrat, C
Staufenbiel, M
Roher, AE
Citation: Ym. Kuo et al., Comparative analysis of amyloid-beta chemical structure and amyloid plaquemorphology of transgenic mouse and Alzheimer's disease brains, J BIOL CHEM, 276(16), 2001, pp. 12991-12998
Authors:
Lue, LF
Walker, DG
Brachova, L
Beach, TG
Rogers, J
Schmidt, AM
Stern, DM
Du Yan, S
Citation: Lf. Lue et al., Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism, EXP NEUROL, 171(1), 2001, pp. 29-45
Authors:
Beach, TG
Walker, DG
Potter, PE
Sue, LI
Fisher, A
Citation: Tg. Beach et al., Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists, BRAIN RES, 905(1-2), 2001, pp. 220-223
Authors:
Beach, TG
Potter, PE
Kuo, YM
Emmerling, MR
Durham, RA
Webster, SD
Walker, DG
Sue, LI
Scott, S
Layne, KJ
Roher, AE
Citation: Tg. Beach et al., Cholinergic deafferentation of the rabbit cortex: a new animal model of A beta deposition, NEUROSCI L, 283(1), 2000, pp. 9-12
Authors:
Beach, TG
Kuo, YM
Spiegel, K
Emmerling, MR
Sue, LI
Kokjohn, K
Roher, AE
Citation: Tg. Beach et al., The cholinergic deficit coincides with A beta deposition at the earliest histopathologic stages of Alzheimer disease, J NE EXP NE, 59(4), 2000, pp. 308-313
Authors:
Kuo, YM
Kokjohn, TA
Watson, MD
Woods, AS
Cotter, RJ
Sue, LI
Kalback, WM
Emmerling, MR
Beach, TG
Roher, AE
Citation: Ym. Kuo et al., Elevated A beta 42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of A beta PP metabolism, AM J PATH, 156(3), 2000, pp. 797-805
Authors:
Cicchetti, F
Vinet, J
Beach, TG
Parent, A
Citation: F. Cicchetti et al., Differential expression of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits by calretinin-immunoreactive neurons in the human striatum, NEUROSCIENC, 93(1), 1999, pp. 89-97
Authors:
Beach, TG
Sue, LI
Scott, S
Sparks, DL
Citation: Tg. Beach et al., Neurofibrillary tangles are constant in aging human nucleus basalis, ALZHEIM REP, 1(6), 1998, pp. 375-380
Authors:
Sparks, DL
Beach, TG
Lukas, RJ
Citation: Dl. Sparks et al., Immunohistochemical localization of nicotinic beta 2 and alpha 4 receptor subunits in normal human brain and individuals with Lewy body and Alzheimer's disease: preliminary observations, NEUROSCI L, 256(3), 1998, pp. 151-154
Risultati:
1-12
|